Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer
- 12 December 2008
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 103 (1), 43-48
- https://doi.org/10.1111/j.1464-410x.2008.08059.x
Abstract
To identify the clinical and pathological variables that predict pathological changes in the significant proportion of men with prostate cancer who have an intermediate- or high-grade biopsy Gleason score (GS) of >or=7 and who are upgraded or downgraded on interpretation of radical prostatectomy (RP) pathological specimens, as GS is critical in treatment decisions. We retrospectively evaluated 1129 patients who had RP after a biopsy showing a GS of >or=7, at our institution, from 2000 to 2007. Complete relevant clinical information was available for all patients. A multivariable logistic regression analysis was used to identify predictors of pathological grading changes. The overall mean age was 61 years, with median prostate-specific antigen (PSA) level of 6 ng/mL. Of the 1129 patients, the surgical GS was upgraded in 296 (26.2%), downgraded in 210 (18.6%), and remained the same in 623 (55.2%). Factors predicting a surgical GS upgrade were a higher PSA level (P = 0.005), presence of perineural invasion (P = 0.043), absence of inflammation (P < 0.001), and absence of associated high-grade prostatic intraepithelial neoplasia (P = 0.02). In an analysis of pathological variables the number of positive cores (P = 0.033) was predictor of upgrading. Large prostate volume (P = 0.004) and low maximum percentage cancer in any core (P = 0.001) were predictors of downgrading. Men with a higher PSA level, perineural invasion and high-volume cancer at biopsy are most likely to be upgraded, while men with a large prostate volume and low-volume cancer at biopsy are more likely to be downgraded. These findings have implications for men with prostate cancer managed without confirmation by RP of their true GS.Keywords
This publication has 16 references indexed in Scilit:
- Prostate Cancer Volume at Biopsy Predicts Clinically Significant UpgradingJournal of Urology, 2008
- Role of prostate biopsy schemes in accurate prediction of Gleason scoresUrology, 2006
- Prostate Needle Biopsy ReportingThe American Journal of Surgical Pathology, 2004
- Comparison of Gleason Scores from Sextant Prostate Biopsies and Radical Prostatectomy SpecimensUrologia Internationalis, 2001
- Primary Gleason Pattern as a Predictor of Disease Progression in Gleason Score 7 Prostate CancerThe American Journal of Surgical Pathology, 2001
- Diagnosis and Staging of Prostatic Carcinoma: What Is Really Necessary?Urologia Internationalis, 1999
- Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate CancerJAMA, 1997
- Prediction of Progression Following Radical ProstatectomyThe American Journal of Surgical Pathology, 1996
- Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading errorUrology, 1995